Extending Hormonal Drugs Therapy for Breast Cancer Might Decrease Risk of Recurrence, New Study Shows

A new study shows that extending the anti-estrogen therapy for hormone-receptor-positive early breast cancer in postmenopausal women can reduce the risk of recurrence and prevent the development of cancer in the other breast.